Table 2 Disease status of the survey respondents and factors affecting COVID-19 vaccination rate.

From: The status and influencing factors of COVID-19 vaccination in patients with COPD

Variables

Number (n)

Percentage (%)

Number of people vaccinated and the coverage rate [n (%)]

χ2

P

Overall

First injection

Second injection

Third injection

First diagnosed as COPD

      

9.154

0.002**

 Yes

1114

59.45

902 (80.97)

61 (6.76)

357 (39.58)

484 (53.66)

  

 No

760

40.55

571 (75.13)

45 (7.88)

269 (47.11)

257 (45.01)

  

Duration of COPD (years)

      

20.287

< 0.001***

 < 5

321

42.24

266 (82.87)

13 (4.89)

120 (45.11)

133 (50.00)

  

 5–10

223

29.34

173 (76.23)

19 (11.18)

82 (48.24)

69 (40.59)

  

 5–10

124

16.31

87 (70.16)

6 (6.90)

47 (54.02)

34 (39.08)

  

 15–20

56

7.37

25 (44.64)

6 (24.00)

12 (48.00)

7 (28.00)

  

 > 20

36

4.74

23 (63.89)

1 (4.35)

8 (34.78)

14 (60.87)

  

Disease awareness

      

1.254

0.263

 Yes

911

48.61

726 (79.69)

53 (7.30)

318 (43.80)

355 (48.90)

  

 No

963

51.39

747 (77.57)

53 (7.10)

308 (41.23)

386 (51.67)

  

Number of acute exacerbations in the last year

      

67.979

< 0.001***

 0

515

27.48

434 (84.27)

27 (6.22)

132 (30.41)

275 (63.36)

  

 1–2

937

40.00

783 (83.56)

38 (4.85)

385 (49.17)

360 (45.98)

  

 3–4

282

15.05

173 (61.35)

19 (10.98)

77 (44.51)

77 (44.51)

  

 ≥ 5

140

7.47

83 (59.29)

22 (26.51)

32 (38.55)

29 (34.94)

  

Number of hospitalizations for acute exacerbations in the last year

      

73.135

< 0.001***

 0

852

45.46

725 (85.09)

33 (4.55)

279 (38.48)

413 (56.97)

  

 1–2

743

39.65

589 (79.27)

36 (6.11)

283 (48.05)

270 (45.84)

  

 3–4

201

10.73

118 (58.71)

22 (18.64)

52 (44.07)

44 (37.29)

  

 ≥ 5

78

4.16

41 (52.56)

15 (36.59)

12 (29.27)

14 (34.15)

  

Comorbidity with other systemic diseasesa

      

105.991

< 0.001***

 Cardiovascular system

841

44.88

612 (72.77)

56 (9.15)

288 (47.06)

268 (43.79)

  

 Nervous system

478

25.51

310 (64.85)

46 (14.84)

145 (46.77)

119 (38.39)

  

 Digestive system

494

26.36

325 (65.79)

42 (13.85)

139 (42.77)

141 (43.38)

  

 Endocrine system

549

29.3

362 (65.94)

44 (12.15)

183 (50.55)

135 (37.29)

  

 Urinary system

418

22.31

267 (63.88)

50 (18.73)

122 (45.69)

95 (35.58)

  

 Haematological system

434

23.36

279 (64.29)

46 (16.49)

122 (43.73)

111 (39.78)

  

 Mental system

396

21.13

262 (66.16)

40 (15.27)

113 (43.13)

109 (41.60)

  

 Snoring

593

31.64

409 (68.97)

55 (13.45)

190 (46.45)

164 (40.10)

  

 Malignant tumour

264

14.09

165 (62.50)

25 (15.15)

68 (41.21)

72 (43.64)

  

 No any other system disease

643

34.31

541 (84.14)

33 (6.10)

184 (34.01)

324 (59.89)

  

 Others

82

4.38

67 (81.71)

6 (8.96)

23 (34.33)

38 (56.72)

  

Degree of dyspnoea

      

32.009

< 0.001***

 0 point

668

35.65

550 (82.34)

34 (6.18)

211 (38.36)

305 (55.45)

  

 1 point

707

37.73

582 (82.32)

32 (5.50)

250 (42.96)

300 (51.55)

  

 2 points

340

18.14

245 (72.06)

26 (10.61)

120 (48.98)

99 (40.41)

  

 3 points

98

5.23

62 (63.27)

10 (16.13)

29 (46.77)

23 (37.10)

  

 4 points

61

3.26

34 (55.74)

4 (11.76)

16 (47.06)

14 (41.18)

  

Degree of cough

      

3.899

0.048*

 0 point

151

8.06

111 (73.51)

18 (16.22)

28 (25.23)

65 (58.56)

  

 1 point

464

24.76

375 (80.82)

21 (5.60)

136 (36.27)

218 (58.13)

  

 2 points

667

35.59

545 (81.71)

26 (4.77)

254 (46.61)

265 (48.62)

  

 3 points

418

22.31

327 (78.23)

22 (6.73)

158 (48.32)

147 (44.95)

  

 4 points

141

7.52

94 (66.67)

16 (17.02)

44 (46.81)

34 (36.17)

  

 5 points

33

1.76

21 (63.64)

3 (14.29)

6 (28.57)

12 (57.14)

  

Degree of expectoration

      

33.575

< 0.001***

 0 point

205

10.94

156 (76.10)

18 (11.54)

44 (28.21)

94 (60.26)

  

 1 point

557

29.72

486 (87.25)

21 (4.32)

204 (41.98)

261 (53.70)

  

 2 points

538

28.71

432 (80.30)

21 (4.86)

204 (47.22)

207 (47.92)

  

 3 points

369

19.69

268 (72.63)

23 (8.58)

124 (46.27)

121 (45.15)

  

 4 points

143

7.63

92 (64.34)

15 (16.30)

38 (41.30)

39 (42.39)

  

 5 points

62

3.31

39 (62.90)

8 (20.51)

12 (30.77)

19 (48.72)

  

Degree of chest tightness

      

3.365

0.067

 0 point

196

10.46

144 (73.47)

16 (11.11)

33 (22.92)

95 (65.97)

  

 1 point

485

25.88

391 (80.62)

22 (5.63)

151 (38.62)

218 (55.75)

  

 2 points

592

31.59

492 (83.11)

27 (5.49)

238 (48.37)

227 (46.14)

  

 3 points

383

20.44

301 (78.59)

16 (5.32)

145 (48.17)

140 (46.51)

  

 4 points

161

8.59

106 (65.84)

23 (21.70)

39 (36.79)

44 (41.51)

  

 5 points

57

3.04

39 (68.42)

2 (5.13)

20 (51.28)

17 (43.59)

  

Degree of wheezing

      

19.5

< 0.001***

 0 point

177

9.45

132 (74.58)

13 (9.85)

33 (25.00)

86 (65.15)

  

 1 point

462

24.65

401 (86.80)

26 (6.48)

151 (37.66)

224 (55.86)

  

 2 points

580

30.95

458 (78.97)

27 (5.90)

209 (45.63)

222 (48.47)

  

 3 points

391

20.86

306 (78.26)

18 (5.88)

152 (49.67)

136 (44.44)

  

 4 points

163

8.7

118 (72.39)

13 (11.02)

58 (49.15)

47 (39.83)

  

 5 points

101

5.39

58 (57.43)

9 (15.52)

23 (39.66)

26 (44.83)

  

COPD influence on home activities

      

22.142

< 0.001***

 0 point

219

11.69

170 (77.63)

15 (8.82)

46 (27.06)

109 (64.12)

  

 1 point

512

27.32

434 (84.77)

25 (5.76)

148 (34.10)

261 (60.14)

  

 2 points

528

28.18

427 (80.87)

22 (5.15)

229 (53.63)

176 (41.22)

  

 3 points

373

19.9

283 (75.87)

22 (7.77)

138 (48.76)

123 (43.46)

  

 4 points

152

8.11

110 (72.37)

15 (13.64)

45 (40.91)

50 (45.45)

  

 5 points

90

4.8

49 (54.44)

7 (14.29)

20 (40.82)

22 (44.90)

  

Outgoing ability

      

27.096

< 0.001***

 0 point

234

12.49

187 (79.91)

13 (6.95)

48 (25.67)

126 (67.38)

  

 1 point

459

24.49

387 (84.31)

25 (6.46)

129 (33.33)

233 (60.21)

  

 2 points

526

28.07

427 (81.18)

23 (5.39)

217 (50.82)

187 (43.79)

  

 3 points

415

22.15

321 (77.35)

18 (5.61)

166 (51.71)

137 (42.68)

  

 4 points

168

8.96

112 (66.67)

19 (16.96)

48 (42.86)

45 (40.18)

  

 5 points

72

3.84

39 (54.17)

8 (20.51)

18 (46.15)

13 (33.33)

  

Sleep quality

      

8.048

0.005**

 0 point

187

9.98

136 (72.73)

15 (11.03)

35 (25.74)

86 (63.24)

  

 1 point

487

25.99

407 (83.57)

25 (6.14)

151 (37.10)

231 (56.76)

  

 2 points

556

29.67

456 (82.01)

26 (5.70)

226 (49.56)

204 (44.74)

  

 3 points

426

22.73

326 (76.53)

17 (5.21)

149 (45.71)

160 (49.08)

  

 4 points

151

8.06

102 (67.55)

16 (15.69)

47 (46.08)

39 (38.24)

  

 5 points

67

3.58

46 (68.66)

7 (15.22)

18 (39.13)

21 (45.65)

  

Energy level

      

23.067

< 0.001***

 0 point

178

9.5

132 (74.16)

12 (9.09)

35 (26.52)

85 (64.39)

  

 1 point

480

25.61

418 (87.08)

25 (5.98)

149 (35.65)

244 (58.37)

  

 2 points

556

29.67

443 (79.68)

22 (4.97)

220 (49.66)

201 (45.37)

  

 3 points

432

23.05

333 (77.08)

25 (7.51)

161 (48.35)

147 (44.14)

  

 4 points

165

8.8

112 (67.88)

18 (16.07)

46 (41.07)

48 (42.86)

  

 5 points

63

3.36

35 (55.56)

4 (11.43)

15 (42.86)

16 (45.71)

  

Regular use of medication for COPD

      

31.48

< 0.001***

 Yes

1320

70.44

1083 (82.05)

56 (5.17)

462 (42.66)

565 (52.17)

  

 No

554

29.56

390 (70.40)

50 (12.82)

164 (42.05)

176 (45.13)

  

Home oxygen therapy (home oxygen)

      

43.307

< 0.001***

 Yes

630

33.62

440 (69.84)

45 (10.23)

208 (47.27)

187 (42.50)

  

 No

1244

66.38

1033 (83.04)

61 (5.91)

418 (40.46)

554 (53.63)

  

Application of non-invasive ventilator

      

81.762

< 0.001***

 Yes

293

15.64

172 (58.70)

36 (20.93)

65 (37.79)

71 (41.28)

  

 No

1581

84.36

1301 (82.29)

70 (5.38)

561 (43.12)

670 (51.50)

  

Current physical condition

      

70.737

< 0.001***

 Good

623

33.24

534 (85.71)

25 (4.68)

161 (30.15)

348 (65.17)

  

 Fair

1051

56.08

837 (79.64)

51 (6.09)

424 (50.66)

362 (43.25)

  

 Deteriorating

200

10.67

102 (51.00)

30 (29.41)

41 (40.20)

31 (30.39)

  
  1. aCardiovascular system (hypertension, coronary heart disease, heart failure, etc.); neurological system (cerebral thrombosis, cerebral haemorrhage, etc.); digestive system (gastro-duodenal ulcers, chronic liver disease, etc.); endocrine system (diabetes mellitus, osteoporosis, etc.) urological system (chronic kidney disease, etc.); haematological system (anaemia, etc.); psychiatric system (anxiety, depression, etc.); and snoring (obstructive sleep apnea, etc.).
  2. COPD, chronic obstructive pulmonary disease; COVID-19, Corona Virus Disease 2019.
  3. *P < 0.05, **P < 0.01, ***P < 0.001.